February 21, 2008 – Teva Pharmaceuticals is pleased to announce the introduction and availability of Oxcarbazepine Tablets. This product is AB rated and bioequivalent to Trileptal®* Tablets. Oxcarbazepine Tablets are available in 150 mg, 300 mg, and 600 mg strengths, in bottle sizes of 100.“Generic pharmaceuticals are playing an increasingly important role in healthcare costcontainment,” states John Denman, V.P. Sales and Marketing.
“Teva Pharmaceuticals continues tolead the way with timely new product launches.”Teva Pharmaceuticals, located in North Wales, Pennsylvania, is the leading pharmaceutical manufacturer for both new and total prescriptions.‡ The company has an aggressive Research andDevelopment effort and one of the best overall ANDA approval records in the industry
No comments:
Post a Comment